Australia's MedAdvisor jumps to two-year high on maiden annual profit forecast

Adheris Health

22/05/2024 02:06

** Shares of MedAdvisor  MDR.AX  rise as much as 17.2% to
A$0.375, their highest since Feb 14, 2022
    ** Stock posts its biggest intraday percentage gain since
April 23
    ** The medical management app maker sees FY net profit after
tax of A$0.5 mln ($333,300.00) to A$0.8 mln, versus a loss of
A$11.3 mln last year
    ** Says co is forecasting its inaugural annual profit
    ** Around 2.1 mln shares change hands, compared with the
30-day average volume of about 520,000
    ** MedAdvisor stock up 48.8% YTD, based on last close

    ($1 = 1.5002 Australian dollars)

 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))